Billboards thanking PM Modi for providing COVID-19 vaccines come up in Canada aninews.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aninews.in Daily Mail and Mail on Sunday newspapers.
India has been praised for supporting vaccine equity.
New Delhi:
Pakistan will soon get made-in-India coronavirus vaccines under the United Global Alliance for Vaccines and Immunization or GAVI, a public-private global health partnership to increase access to immunisation in poor countries. Pakistan is one of the 92 lower-income economies eligible for support under the Gavi COVAX Advance Market Commitment (Gavi COVAX AMC), GAVI spokesperson told NDTV.
14.64 million doses of Covishield- developed by Pune-based Serum Institute of India - have been allotted for the country between February and May, the spokesperson said.
Adar Poonawalla s Serum Institute is the world s largest vaccine maker. Pakistan has logged over 5.95 lakh cases of coronavirus so far.
Pakistan to get ‘Made in India’ coronavirus vaccines soon
10 Mar 2021 Pakistan will be getting 45 million doses of Oxford-AstraZeneca s coronavirus vaccine. Gulf Today Report
Pakistan will soon get made-in-India coronavirus vaccines, sources have said, under the United Global Alliance for Vaccines and Immunisation or GAVI, a public-private global health partnership to increase access to immunisation in poor countries.
Pakistan will be getting 45 million doses of Oxford-AstraZeneca s coronavirus vaccine, being manufactured in India, according to reports in sections of the Indian media.
READ MORE
India has supplied vaccines to 65 countries so far under three categories – as part of the global vaccine alliance, in the form of grant or aid (free of cost), and through commercial sales. All of India s neighbours, except Pakistan, are among the countries that got these vaccines.
Expert panel approves Covaxin for emergency use, waives off clinical trial condition
Expert panel approves Covaxin for emergency use, waives off clinical trial condition
A subject expert committee has approved Bharat Biotech s Covaxin for emergency use authorisation in India and removed the clinical trial mode condition on its use..
advertisement
UPDATED: March 11, 2021 07:38 IST
Covaxin was earlier granted emergency use authorisation but it was only in the clinical trial mode. This condition has now been waived off. (File photo)
The subject expert committee (SEC) of the Central Drugs Standard Control Organisation has approved Bharat Biotech s Covaxin for emergency use authorisation in India.
Vaccine, India, COVID- Edexlive edexlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from edexlive.com Daily Mail and Mail on Sunday newspapers.